Lentiviral vectors ready for prime-time

Nature Biotechnology

Volumn 25, Issue 1, 2007, Pages 65-66

  Kohn, Donald B ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; VECTORS;

CLINICAL TRIAL; GENE-THERAPY VECTOR; LENTIVIRAL VECTOR;

GENES;

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

BIOSAFETY; CLINICAL TRIAL; GENE DELETION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEUKAPHERESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

ADULT; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; MIDDLE AGED; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 33846160971     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0107-65     Document Type: Short Survey

References (10)

1. Podsakoff, G.M., Engel, B. & Kohn, D.B. Biol. Blood Marrow Transplant. 11, 972-976 (2005).
2. Levine, B.L. et al. Proc. Natl. Acad. Sci. USA 103, 17372-17377 (2006).
3. Naldini, L. et al. Science 272, 263-267 (1996).
4. Zufferey, R. et al. Nat. Biotechnol. 15, 871-875 (1997).
5. May, C. et al. Nature 406, 82-86 (2000).
6. Hacein-Bey-Abina, S. et al. Science 302, 415-419 (2003).
7. Bushman, F. et al. Nat. Rev. Microbiol. 3, 848-858 (2005).
8. Montini, E. et al. Nat. Biotechnol. 24, 687-696 (2006).
9. Humeau, L.M. et al. Mol. Ther. 9, 902-913 (2004).
10. Dropulic, B., Hermankova, M. & Pitha, P.M. Proc. Natl. Acad. Sci. USA 93, 11103-11108 (1996).